BRADY MOFFETT to Anti-Arrhythmia Agents
This is a "connection" page, showing publications BRADY MOFFETT has written about Anti-Arrhythmia Agents.
Connection Strength
2.360
-
Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Antiarrhythmics. Pediatr Crit Care Med. 2016 Mar; 17(3 Suppl 1):S49-58.
Score: 0.487
-
Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database. Cardiol Young. 2015 Aug; 25(6):1080-5.
Score: 0.440
-
Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015 Jan; 36(1):146-50.
Score: 0.437
-
High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol. 2011 Oct; 32(7):896-903.
Score: 0.349
-
Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment. Pharmacotherapy. 2006 Dec; 26(12):1687-93.
Score: 0.256
-
Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. Pediatr Cardiol. 2015 Oct; 36(7):1465-9.
Score: 0.115
-
Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. J Pediatr. 2015 Jan; 166(1):115-8.
Score: 0.110
-
Amiodarone monitoring practices in pediatric hospitals in the United States. Pediatr Cardiol. 2013; 34(8):1762-6.
Score: 0.100
-
"Second line medications" for supraventricular arrhythmias in children: In-hospital efficacy and adverse events during treatment initiation of sotalol and flecainide. J Cardiovasc Electrophysiol. 2021 08; 32(8):2207-2215.
Score: 0.044
-
Perioperative atrial tachycardia is associated with increased mortality in infants undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2012 Aug; 144(2):396-401.
Score: 0.023